Mativ Holdings Past Earnings Performance
Past criteria checks 0/6
Mativ Holdings's earnings have been declining at an average annual rate of -72.2%, while the Chemicals industry saw earnings growing at 13% annually. Revenues have been growing at an average rate of 20.6% per year.
Key information
-72.2%
Earnings growth rate
-64.6%
EPS growth rate
| Chemicals Industry Growth | 12.4% |
| Revenue growth rate | 20.6% |
| Return on equity | -53.5% |
| Net Margin | -25.1% |
| Next Earnings Update | 08 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Mativ Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 2,026 | -508 | 324 | 21 |
| 30 Sep 23 | 2,629 | -435 | 356 | 31 |
| 30 Jun 23 | 2,682 | -5 | 359 | 31 |
| 31 Mar 23 | 2,440 | -17 | 321 | 31 |
| 31 Dec 22 | 1,637 | -70 | 263 | 19 |
| 30 Sep 22 | 1,503 | -14 | 238 | 18 |
| 30 Jun 22 | 1,335 | 32 | 208 | 18 |
| 31 Mar 22 | 1,559 | 68 | 233 | 22 |
| 31 Dec 21 | 931 | 1 | 177 | 12 |
| 30 Sep 21 | 1,329 | 50 | 204 | 18 |
| 30 Jun 21 | 1,225 | 62 | 182 | 16 |
| 31 Mar 21 | 1,101 | 82 | 157 | 14 |
| 31 Dec 20 | 1,074 | 83 | 153 | 14 |
| 30 Sep 20 | 1,034 | 88 | 148 | 14 |
| 30 Jun 20 | 1,011 | 91 | 147 | 13 |
| 31 Mar 20 | 1,026 | 90 | 144 | 13 |
| 31 Dec 19 | 1,023 | 85 | 141 | 14 |
| 30 Sep 19 | 1,033 | 72 | 134 | 14 |
| 30 Jun 19 | 1,037 | 85 | 131 | 14 |
| 31 Mar 19 | 1,037 | 91 | 132 | 14 |
| 31 Dec 18 | 1,041 | 94 | 130 | 15 |
| 30 Sep 18 | 1,028 | 60 | 134 | 17 |
| 30 Jun 18 | 1,026 | 45 | 135 | 17 |
| 31 Mar 18 | 1,011 | 41 | 135 | 18 |
| 31 Dec 17 | 982 | 34 | 133 | 18 |
| 30 Sep 17 | 945 | 78 | 123 | 18 |
| 30 Jun 17 | 897 | 71 | 118 | 18 |
| 31 Mar 17 | 859 | 75 | 110 | 18 |
| 31 Dec 16 | 840 | 82 | 107 | 18 |
| 30 Sep 16 | 851 | 87 | 108 | 16 |
| 30 Jun 16 | 826 | 94 | 97 | 16 |
| 31 Mar 16 | 791 | 92 | 95 | 15 |
| 31 Dec 15 | 764 | 90 | 91 | 14 |
| 30 Sep 15 | 736 | 87 | 80 | 14 |
| 30 Jun 15 | 756 | 84 | 85 | 14 |
| 31 Mar 15 | 778 | 85 | 84 | 15 |
| 31 Dec 14 | 794 | 89 | 84 | 16 |
| 30 Sep 14 | 809 | 60 | 81 | 16 |
| 30 Jun 14 | 790 | 66 | 78 | 16 |
| 31 Mar 14 | 783 | 71 | 75 | 16 |
| 31 Dec 13 | 773 | 78 | 71 | 15 |
| 30 Sep 13 | 771 | 118 | 75 | 14 |
| 30 Jun 13 | 782 | 123 | 74 | 13 |
Quality Earnings: MH2 is currently unprofitable.
Growing Profit Margin: MH2 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MH2 is unprofitable, and losses have increased over the past 5 years at a rate of 72.2% per year.
Accelerating Growth: Unable to compare MH2's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MH2 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-19.4%).
Return on Equity
High ROE: MH2 has a negative Return on Equity (-53.49%), as it is currently unprofitable.